Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elanco Animal Health Incorporated Common Stock (NY:ELAN)

23.13 -0.42 (-1.77%)
Streaming Delayed Price Updated: 12:37 PM EDT, Sep 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Elanco Director Purchases 40,000 Shares for $936,000 ↗
Purchasing 40,000 shares is a bullish signal for shareholders. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Insiders Are Betting Big on These 3 Healthcare Stocks ↗
Insiders are buying shares of Braveheart Bio, BlossomHill Therapeutics and Elanco, three health care stocks with differing risk profiles, analyst ratings, and pipeline catalysts ahead. 
Via MarketBeat
Topics Initial Public Offering
News headline image
3 Stocks Under $50 That Concern Us
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline... 
Via StockStory
News headline image
2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
Topics Economy Energy
Elanco Animal Health (NYSE:ELAN) Q2 Earnings Beat, Lifts Full-Year Outlook ↗
Via Chartmill
Topics Earnings
Elanco Animal Health Inc (NYSE:ELAN) Technical Breakout Setup Scores 10/10 Technical Rating and 9/10 Setup Quality ↗
Via Chartmill
Elanco Animal Health (NYSE:ELAN) Soars After Strong Q1 Beat, Raises Full-Year Outlook ↗
Via Chartmill
News headline image
Director's Confidence Visible as Elanco Leader Buys 10,000 Shares ↗
Insider buys into strength as the Elanco stock price has outperformed the S&P 500 over the last 12 months. 
Via The Motley Fool
Topics Regulatory Compliance Stocks
News headline image
1 of Wall Street’s Favorite Stocks on Our Watchlist and 2 We Find Risky
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
Elanco (ELAN) Q2 2026 Earnings Call Transcript ↗
Zenrelia and Credelio Quattro drove blockbuster growth and margin expansion. 
Via The Motley Fool
Topics Earnings
News headline image
5 Must-Read Analyst Questions From Elanco’s Q2 Earnings Call
Elanco’s results for the second quarter were positively received by the market, reflecting momentum across both its Pet Health and Farm Animal businesses. Ma... 
Via StockStory
Topics Earnings
News headline image
Elanco Animal Health Q2 Earnings Call Highlights ↗
Elanco Animal Health (NYSE:ELAN) reported second-quarter 2026 revenue of $1.368 billion, up 10% on a reported basis and 8% organically in constant currency, as demand for new pet-health products and... 
Via MarketBeat
Topics Earnings
News headline image
ELAN Q2 Deep Dive: Blockbuster Launches and Portfolio Expansion Drive Outperformance
Animal health company Elanco (NYSE:ELAN) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 10.2% year on year to $1.37 bill... 
Via StockStory
News headline image
Elanco’s (NYSE:ELAN) Q2 CY2026: Strong Sales, Stock Soars
Animal health company Elanco (NYSE:ELAN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 10.2% year on year to $1.37 billion... 
Via StockStory
News headline image
Elanco (ELAN) Reports Q2: Everything You Need To Know Ahead Of Earnings
Animal health company Elanco (NYSE:ELAN) will be reporting results this Wednesday before market hours. Here’s what you need to know. Elanco beat analysts’ re... 
Via StockStory
News headline image
1 Mid-Cap Stock to Own for Decades and 2 We Question
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory
Topics Retirement
News headline image
1 Profitable Stock to Target This Week and 2 We Avoid
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
2 Cash-Producing Stocks on Our Buy List and 1 That Underwhelm
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks We Think Twice About
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
Via StockStory
News headline image
3 Healthcare Stocks We Keep Off Our Radar
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl... 
Via StockStory
News headline image
What This Fund's $20 Million Sale Says About a Packaging Giant Facing a Turnaround Test ↗
Graphic Packaging supplies fiber-based packaging for global consumer and foodservice brands, with a focus on sustainability and scale. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What to Know About This Fund's $85 Million Lionsgate Buy During a Breakout Quarter ↗
Lionsgate Studios leverages a vast film and TV library to serve global broadcasters, streamers, and distributors with premium content. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Q1 Rundown: Elanco (NYSE:ELAN) Vs Other Pharmaceuticals Stocks
Looking back on pharmaceuticals stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Elanco (NYSE:ELAN) and its peers. The pha... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Black Creek trims PriceSmart after a strong run — conviction intactBlack Creek trims PriceSmart after a strong run — conviction intact ↗
PriceSmart runs membership warehouse clubs across the Americas, providing essential goods and services to value-driven customers. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Reasons to Sell ELAN and 1 Stock to Buy Instead
Since November 2025, Elanco has been in a holding pattern, floating around $21.39. The stock also fell short of the S&P 500’s 11.5% gain during that period. ... 
Via StockStory
Topics Stocks
News headline image
5 Insightful Analyst Questions From Elanco’s Q1 Earnings Call
Elanco’s first quarter results were met with a positive market reaction, as management pointed to broad-based revenue growth across its pet health and farm a... 
Via StockStory
Topics Earnings
News headline image
Elanco Animal Health Q1 Earnings Call Highlights ↗
Elanco Animal Health (NYSE:ELAN) raised its 2026 outlook after reporting stronger-than-expected first-quarter results, citing broad-based growth across pet health and farm animal businesses,... 
Via MarketBeat
Topics Earnings
News headline image
ELAN Q1 Deep Dive: Innovation Products and Margin Expansion Steer Strong Start
Animal health company Elanco (NYSE:ELAN) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 14.9% year on year to $1.37 bill... 
Via StockStory
News headline image
Elanco (ELAN) Q1 2026 Earnings Transcript ↗
Elanco (ELAN) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Economy
News headline image
Elanco’s (NYSE:ELAN) Q1 CY2026 Sales Beat Estimates
Animal health company Elanco (NYSE:ELAN) announced better-than-expected revenue in Q1 CY2026, with sales up 14.9% year on year to $1.37 billion. The company ... 
Via StockStory
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.